Forward Pharma A Probability of Future Stock Price Finishing Under 1.77

FWPDelisted Stock  USD 2.56  0.00  0.00%   
Forward Pharma's future price is the expected price of Forward Pharma instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Forward Pharma A performance during a given time horizon utilizing its historical volatility. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
  
Please specify Forward Pharma's target price for which you would like Forward Pharma odds to be computed.

Forward Pharma Target Price Odds to finish below 1.77

The tendency of Forward Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to $ 1.77  or more in 90 days
 2.56 90 days 1.77 
about 5.1
Based on a normal probability distribution, the odds of Forward Pharma to drop to $ 1.77  or more in 90 days from now is about 5.1 (This Forward Pharma A probability density function shows the probability of Forward Stock to fall within a particular range of prices over 90 days) . Probability of Forward Pharma A price to stay between $ 1.77  and its current price of $2.56 at the end of the 90-day period is about 44.05 .
Considering the 90-day investment horizon Forward Pharma A has a beta of -0.16. This usually indicates as returns on the benchmark increase, returns on holding Forward Pharma are expected to decrease at a much lower rate. During a bear market, however, Forward Pharma A is likely to outperform the market. Additionally Forward Pharma A has an alpha of 0.1369, implying that it can generate a 0.14 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Forward Pharma Price Density   
       Price  

Predictive Modules for Forward Pharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Forward Pharma A. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Forward Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
2.562.562.56
Details
Intrinsic
Valuation
LowRealHigh
1.771.772.82
Details
Naive
Forecast
LowNextHigh
2.972.972.97
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
2.542.572.60
Details

Forward Pharma Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Forward Pharma is not an exception. The market had few large corrections towards the Forward Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Forward Pharma A, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Forward Pharma within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.14
β
Beta against Dow Jones-0.16
σ
Overall volatility
0.49
Ir
Information ratio -0.0016

Forward Pharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Forward Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Forward Pharma A can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Forward Pharma A is not yet fully synchronised with the market data
Forward Pharma A has a very high chance of going through financial distress in the upcoming years
Reported Net Loss for the year was (1.89 M) with profit before taxes, overhead, and interest of 0.
Forward Pharma A has about 70.77 M in cash with (2.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

Forward Pharma Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Forward Stock often depends not only on the future outlook of the current and potential Forward Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Forward Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares OutstandingM
Cash And Short Term Investments70.8 M

Forward Pharma Technical Analysis

Forward Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Forward Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Forward Pharma A. In general, you should focus on analyzing Forward Stock price patterns and their correlations with different microeconomic environments and drivers.

Forward Pharma Predictive Forecast Models

Forward Pharma's time-series forecasting models is one of many Forward Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Forward Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Forward Pharma A

Checking the ongoing alerts about Forward Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Forward Pharma A help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Forward Pharma A is not yet fully synchronised with the market data
Forward Pharma A has a very high chance of going through financial distress in the upcoming years
Reported Net Loss for the year was (1.89 M) with profit before taxes, overhead, and interest of 0.
Forward Pharma A has about 70.77 M in cash with (2.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Consideration for investing in Forward Stock

If you are still planning to invest in Forward Pharma A check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Forward Pharma's history and understand the potential risks before investing.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Bonds Directory
Find actively traded corporate debentures issued by US companies
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments